Federal inspectors found that Resident 12, who had received a kidney transplant just one month earlier, went without the critical medications on October 15 and 16. The resident was subsequently hospitalized with sepsis.
"The resident received a kidney transplant last month," the transplant doctor told inspectors on October 23. "From the laboratory results obtained in the hospital from current admission it has appeared that the resident had not received any antirejection medication."
The consequences were severe and immediate. "The resident not getting the antirejection medication as ordered could cause the body to reject the transplanted organ requiring another surgery to remove the organ," the transplant doctor explained.
LPN F, who served as charge nurse during the incident, told inspectors the medications simply weren't available. "The resident's medications were not administered on 10/15/25 or 10/16/25 as reported to him/her by the CMT," the nurse said. "He/She never saw the resident's medication during his/her shifts on 10/15/25 or 10/16/25."
The charge nurse had alerted the director of nursing about the missing medications. "The DON was aware that the resident's medication were not being administered because he/she told the DON that meds were not available and being administered," LPN F said.
Yet no immediate action was taken to obtain the life-saving drugs.
The resident confirmed the medication failure. "Resident #12 said he/she did not remember receiving any medications while at the facility," according to the inspection report.
A hospital registered nurse who treated the resident after the nursing home stay explained the gravity of the situation. "Resident #12 was admitted to the hospital with sepsis. That would mean that the resident was severely sick. Missing antirejection medication was bad and could cause the transplanted organ to be rejected."
The facility's corporate director of nursing acknowledged the critical nature of such medications during an October 23 interview. "He/She would expect high level medication such as anti-rejection medications to be on site when a patient arrived on site," the corporate director said. "He/She would not expect a resident to miss doses of anti-rejection medication."
This expectation directly contradicted what actually happened to Resident 12.
The administrator claimed complete ignorance of both the resident's medical status and the medication failure. "He/She was not aware that the resident was a post-transplant patient," the administrator told inspectors. "He/She was not aware that the resident was not receiving his/her medication."
The administrator added: "He/She would have expected all medication to be administered and no doses to be missed."
The chief operating officer expressed similar expectations that were not met in practice. "He/She would expect that all residents received their medication and treatments as ordered," the COO said. "He/She would expect the clinical team and the administrator ensured safe medication administration of all of a resident's medication."
The COO also emphasized the facility's responsibility for coordinating care during transfers. "He/She expected staff to coordinate care with transferring facilities to ensure that resident's medication were all transcribed and continued."
This coordination clearly failed for Resident 12.
According to the inspection findings, someone at the facility "was responsible for ensuring the resident's medication were ordered STAT and at the facility upon admission." Yet the anti-rejection medications were neither ordered promptly nor available when the transplant patient arrived.
The violation reached the level of immediate jeopardy, the most serious category of nursing home deficiency. Federal inspectors determined that few residents were affected, but the harm to those residents was severe and immediate.
The facility implemented corrective actions during the inspection that temporarily lowered the severity level. However, inspectors noted that a final revisit would be conducted to determine full compliance with participation requirements.
The case emerged from multiple complaints filed against the facility. Federal records show eight separate complaint numbers associated with the inspection: 2645193, 2646488, 2642955, 2633865, 2636127, 2640626, 2646855, and 2648264.
For transplant patients, anti-rejection medications represent the difference between a successful transplant and organ failure. These drugs suppress the immune system's natural tendency to attack foreign tissue, including transplanted organs. Missing even a few doses can trigger rejection, potentially requiring emergency surgery to remove the failing organ.
The transplant doctor's laboratory findings suggested Resident 12 had received no anti-rejection medication at all during the nursing home stay. This created a medical emergency that required hospitalization for sepsis, a life-threatening infection that can occur when the body's response to infection causes widespread inflammation.
The administrator's lack of awareness about having a post-transplant patient in the facility raises questions about admission procedures and communication systems. Transplant patients require specialized care and monitoring, with anti-rejection medications typically considered among the most critical prescriptions a facility can manage.
The corporate director of nursing's statement that such medications should be "on site when a patient arrived" suggests the facility had policies in place that weren't followed in this case. The gap between policy and practice left a vulnerable resident without life-sustaining medication for 48 hours.
LPN F's testimony reveals that nursing staff recognized the problem and reported it to supervisors, but the medications remained unavailable. This suggests a breakdown in the facility's systems for obtaining urgent medications, particularly for high-risk residents with specialized needs.
The chief operating officer's emphasis on coordination with transferring facilities highlights another potential failure point. Transplant patients typically transfer from hospitals with detailed medication regimens that must continue without interruption. The facility's inability to maintain this continuity of care created the immediate jeopardy situation.
Federal inspectors determined the facility had removed the immediate jeopardy violation by the time they completed their onsite visit, but noted that substantial compliance with all participation requirements remained under review. The facility still faced potential state-level enforcement actions for what regulators classified as a Class I violation under Missouri law.
Resident 12's experience illustrates the potentially fatal consequences when nursing homes fail to manage medications for the most vulnerable residents. The resident survived the medication lapse and subsequent hospitalization, but faced the ongoing risk that the transplanted kidney might reject due to the interruption in anti-rejection therapy.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Golden Years Center For Rehab and Healthcare from 2025-10-29 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Golden Years Center For Rehab and Healthcare
- Browse all MO nursing home inspections